Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model

Fig. 2

Kaplan–Meier survival curves of IC + CCRT, CCRT+AC, and IC + CCRT+AC treatment groups. There were no differences in survival outcomes among treatment groups (P > 0.05 by rank-sum test). The primary endpoint is failure-free survival (FFS) rate, defined as the time between the initial pathological diagnosis of nasopharyngeal carcinoma (NPC) and treatment failure or final follow-up. Secondary endpoints include overall survival (OS), locoregional failure-free survival (LFFS), and distant failure-free survival (DFFS). IC = induction chemotherapy. AC = adjuvant chemotherapy. CCRT = concurrent chemoradiotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us